好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Use of Traditional Medicine for Primary Headache Disorders in Kuwait.
Headache
P5 - Poster Session 5 (5:30 PM-6:30 PM)
13-003
To study Traditional Medicine use frequency and efficacy among primary headache patients.
Traditional Medicine (TM) is widely used for the treatment of headache in Kuwait however, research data remain poorly documented. Physicians are often faced with patients who use or inquire about TM.

A cross sectional study was conducted in a Headache clinic over 6 months. Patients diagnosed with primary headache of both genders aged 18-65 years were included. Data was collected by self-reported questionnaire, it included demographics, characteristics of headache (frequency, duration, severity and, frequency of analgesic use) before and 3 months after the final TM session and, type of TM used (cupping, head banding and, herbal medicine).

A total of 279 patients diagnosed with primary headache were included. The mean age is (40.32 ± 11.75) years; females represented (79.6%). Most patients(n=195; 69.9%) reported using TM before presentation, mainly cupping(47.3%). Cultural/religious beliefs were the main reason behind seeking TM in (51.3%). Patients who sought TM had more frequent headache episodes, longer attacks and higher analgesic use respectively before presentation(9.66 ± 7.39 versus 4.14 ± 2.72; p < 0.001), (41.23± 27.76 versus 32.19 ± 23.29; p <. 0009), (8.23+7.70 versus 3.18± 3.06; p < 0.001). Three months after the final TM session, there was no significant reduction in the frequency of headache (9.19 ± 7.33 versus 8.99± 7.59; p <0.50), days of analgesic use per month(7.45± 7.43 versus 6.77± 6.93; p <0.09) and duration of headache (41.23 ± 27.76 versus 41.59 ± 27.69; p <0.78). However, there was a significant reduction of headache severity(p <0.02). Few patients(17.9%) reported adverse events. Most patients were not satisfied after receiving TM.


TM is widely used by headache sufferers therefore treating physicians should be aware of it to monitor potential benefits or adverse events. TM was not effective in reducing headache attacks and severity.

Authors/Disclosures
Fatemah Alshawaf, MD (Kuwait Institute for Medical Specializations (KIMS))
PRESENTER
Dr. Alshawaf has nothing to disclose.
Jasem Y. Al-Hashel, MD (IBN Sina Hospital, AlSabah Medical Area, Neurology Department) Dr. Al-Hashel has nothing to disclose.
No disclosure on file
Raed Alroughani, MD, FAAN Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, AstraZeneca, Novartis, Merck, Roche, Sanofi. Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AstraZeneca, Biogen, Novartis, Merck, Roche, Sanofi.